Bayer should invest $ 150 million in Brazil next year

The German group Bayer must invest $ 150 million in Brazil in 2014. Largest company in the chemical sector and one of the 10 largest pharmaceutical companies in the world, the company is betting on the growth of the country. "If Brazil grow like in 2013, will be cause for cheer", believes the Chairman of the Bayer Group in Brazil, Theo van der Loo.
In recent years, the company has been constantly growing in the country. Worldwide, for the second consecutive year the Brazil ranks as the fifth largest market of company and number one in Latin America.
This year, the contributions should add $ 172 million. Value destined mainly to the construction of new laboratories and in the development of the EcoCommercial Building program that foresees the construction of units with zero carbon emissions. "In addition, we invested R $ 5 million for the construction of a mobile bridge (now nearing completion) which will link the company headquarters in São Paulo (site Help) to the train station in Santo Amaro", says the Executive. The project aims to benefit more than 15 thousand people living or working in the area, reducing the emission of 300 tons of carbon dioxide per year. "This will greatly improve the traffic in the region", says the Executive.
Research Development & (P&D) should also have strong investments, which ensures the lab post among those who have new products in its pipeline, expected to launch in 2014 and 2015. Are medicines in the areas of women's health, Oncology, cardiology, consumer care and dermatology.
"Innovation is another pillar of Bayer, we believe this is the key to maintaining leadership in all markets where we operate, so we invest in Research & Development", he adds.
For all that, the President of the company in Brazil believe that the DCI Award-most admired companies, Chemical Petrochemical & category, confirms the recognition of the Bayer chemical industries between, one of the sectors of more weight in the country's economy. "The award arrived at a very special moment, because this year we celebrated 150 years of existence in the world and 117 in Brazil. The conquest also proves the commitment and dedication of all the more than 4,500 professionals who work in the Brazilian units, and engagement in our values ", says the Executive.
In 2012, Bayer has invested 3 billion euros globally in the chemical area, about 8% of sales recorded in the same year by the group. In the area of health, the investment was in the order of 13%. Last year, the three business divisions (HealthCare, CropScience and MaterialScience) have generated sales of $ 5.7 billion, a growth of 26% over the previous year.